Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Pruned Pipeline Producing Attractive Respiratory And Neurology Fruits

Dec 13 2018

• By Alexandra Shimmings

Grapes — Pruning Often Bears Good Fruit

Related Content

Novartis Goes Big On Gene Therapy With $8.7bn AveXis Acquisition

Apr 09 2018

Novartis Gives Up On Rituxan Biosimilar For US Market

Nov 05 2018

Narasimhan: Novartis' Specialized Portfolio Will Lead To Bigger Breakthroughs And Greater Value

Nov 06 2018

Eight Things To Know From Novartis' Third Quarter Call

Oct 18 2018

Novartis' Siponimod Heads Towards Regulators As Experts Question Its Effects

Mar 23 2018

Alarm As Novartis Exits Antibiotics Space

Jul 12 2018

CANTOS: Modest CV And Intriguing Lung Cancer Benefit With Canakinumab

Aug 27 2017

Related Companies

Boston Pharmaceuticals Inc.

Spark Therapeutics, Inc.

Biogen, Inc.

Roche Holding AG

PTC Therapeutics, Inc.

Merck & Co., Inc.

Novartis AG

Additional Topics

Companies Research & Development Respiratory Cancer Neurology BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window